Laurus Labs share price jumps near ₹1,103, close to a record high. Strong Q3 results, rising CDMO growth and bullish analyst ...

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. The fair value estimate for Laurus Labs has been reset from ₹863.13 to ₹913.47, ...

SUNNYVALE, Calif., May 30, 2024 /PRNewswire/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of ...

In comparison to its peers, Laurus Labs has delivered stronger execution, reporting a 30% growth from the previous year and ...

The Contract Development and Manufacturing Organization (CDMO) industry in India is a fast-growing segment of the pharmaceutical sector that provides outsourced drug development and manufacturing ...

Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 1280 in its research report dated February 25, 2026.

Laurus Labs, a pharma company, is showing signs of recovery after a recent dip. Experts suggest short-term traders with a ...

Laurus Labs has received a tentative nod from the Food and Drug Administration for Dolutegravir 5 mg and 10 mg for pediatric ARV treatment. This pediatric drug administration through oral dispersible ...

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Laurus Labs is back in focus as the latest research update resets the stock's price ...

Laurus Labs share price rose over 2% during Monday's trading session to touch an 52-week high of ₹720.90 apiece on the BSE, marking the stock's third consecutive day of gains in a bullish trend. So ...

The strategic alliance includes an initial seven high-value advanced intermediates and active pharmaceutical ingredients, including Willow's corticosteroid programs The agreement with Laurus is the ...